These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8183871)

  • 1. [Monitoring sarcoidosis therapy with immunopathologic parameters].
    Müller-Quernheim J
    Pneumologie; 1994 Feb; 48(2):47-9. PubMed ID: 8183871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosis.
    Burkhardt O; Lode H; Welte T; Merker HJ
    Micron; 2007; 38(6):572-9. PubMed ID: 17127071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.
    Kieszko R; Krawczyk P; Chocholska S; Bojarska-Junak A; Jankowska O; Król A; Roliński J; Milanowski J
    Respir Med; 2007 Mar; 101(3):645-54. PubMed ID: 16889950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sarcoidosis of the lung: clinical course and inflammatory activity].
    Schmidt M; Wirtz H
    Pneumologie; 1995 Mar; 49(3):226-32. PubMed ID: 7753769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural localization of anionic sites and lectin-binding sites in sarcoid human alveolar macrophages during interaction with T-lymphocytes.
    Thole AA; Stumbo AC; Costa CH; Milward G; Porto LC; Carvalho L
    J Submicrosc Cytol Pathol; 1999 Jan; 31(1):131-5. PubMed ID: 10363360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.
    Agostini C; Trentin L; Facco M; Sancetta R; Cerutti A; Tassinari C; Cimarosto L; Adami F; Cipriani A; Zambello R; Semenzato G
    J Immunol; 1996 Jul; 157(2):910-8. PubMed ID: 8752945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokine levels in induced sputum and bronchoalveolar lavage fluid in pulmonary sarcoidosis.
    Balamugesh T; Behera D; Bhatnagar A; Majumdar S
    Indian J Chest Dis Allied Sci; 2006; 48(3):177-81. PubMed ID: 18610674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis.
    Moller DR; Forman JD; Liu MC; Noble PW; Greenlee BM; Vyas P; Holden DA; Forrester JM; Lazarus A; Wysocka M; Trinchieri G; Karp C
    J Immunol; 1996 Jun; 156(12):4952-60. PubMed ID: 8648147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of sarcoidosis].
    Müller-Quernheim J
    Versicherungsmedizin; 1995 Dec; 47(6):216-21. PubMed ID: 8571499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The activity of immunocompetent cells and macrophages in pulmonary sarcoidosis (in comparison to tuberculosis)].
    Gergert VIa; Abramova ZP; Kosmiadi GA
    Probl Tuberk; 1996; (1):35-8. PubMed ID: 8907484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sarcoidosis: immunopathology and criteria of biological activity].
    Müller-Quernheim J; Ménard O
    Rev Mal Respir; 1995; 12(6):525-31. PubMed ID: 8677346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of T-lymphocytes in pursuit of sarcoidosis antigens].
    Grunewald J; Eklund A
    Lakartidningen; 2002 Sep; 99(36):3508-13, 3515. PubMed ID: 12362750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the percentage of activated lymphocytes in bronchoalveolar lavage fluid in patients with clinical improvement of sarcoidosis].
    Piesiak P; Jankowska R; Passowicz-Muszyńska E
    Wiad Lek; 2006; 59(9-10):644-8. PubMed ID: 17338122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alveolar macrophage section of cytokines and levels of phospholipids in the bronchoalveolar washing in pulmonary sarcoidosis and tuberculosis].
    Taganovich AD; Kotovich IL; Borodina GL
    Probl Tuberk; 2002; (8):23-6. PubMed ID: 12474461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and immunobiological observations on the inflammatory activity of sarcoidosis].
    Müller-Quernheim J
    Pneumologie; 1996 Jan; 50(1):40-8. PubMed ID: 8774933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in interleukin-1 released by pulmonary alveolar macrophage in patients with interstitial lung disease].
    Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):90-2, 124. PubMed ID: 8221960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
    Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
    J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of surface adhesion molecules on memory T cells at the site of immune-mediated inflammation.
    Gerli R; Agea E; Bertotto A; Tognellini R; Muscat C; Cernetti C; Spinozzi F; Grignani F
    Sarcoidosis; 1991 Sep; 8(2):188-9. PubMed ID: 1669998
    [No Abstract]   [Full Text] [Related]  

  • 19. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.
    Bäumer I; Zissel G; Schlaak M; Müller-Quernheim J
    Lung; 1997; 175(2):105-16. PubMed ID: 9042667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases.
    Zissel G; Ernst M; Schlaak M; Müller-Quernheim J
    J Investig Med; 1997 Feb; 45(2):75-86. PubMed ID: 9084578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.